The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories’ baby-formula business, the company said.
The SEC’s enforcement division sent a subpoena to Abbott ABT,
In addition, Abbott said it received a civil investigative demand from the FTC in January seeking information in connection with the agency’s investigation of companies that bid for infant-formula supply contracts with a federal program.
Abbott, of Abbott Park, Ill., is cooperating with the government investigations, a spokesman said.
An expanded version of this report appears at WSJ.com.
Top stories from WSJ.com
Sen. John Fetterman Is Hospitalized for Depression
Facebook Parent Meta Gives Thousands of Workers Subpar Review
